Combinostics at ECR 2023

March 1-5, 2023  |  Vienna, Austria
Booth EXPO X1, AIX area AI-36

Attending European Congress of Radiology (ECR) 2023? Schedule some time to learn more about our cNeuro® suite, including the cMRI™ and cDSI™ applications, the pending cPET™ application, industry-first Dementia Differential Analysis report, and new clinically focused cMRI reports for dementia, multiple sclerosis, traumatic brain injuries, and epilepsy.

Our complete AI software solution supports entire patient care pathways of major neurological disorders, including early detection, differentiation of diagnosis, treatment planning, and monitoring.

Using a combination of science and innovative AI technology, we aim to make a difference in the lives of patients with neurological disorders.

Our solutions put the focus on patients by providing objective, reliable insights for confident, evidence-based diagnostic and management decisions. Radiologists are better equipped to support referring clinicians and their patients with credible, validated imaging quantification and unique differential reporting for major neurological disorders.

Presentation in the AI Theatre

Join us for a presentation given by our CEO, Richard Hausmann, to learn more about how you can support the entire patient pathway for major neurodegenerative disorders.

Supporting the entire patient pathway: Early detection, diagnosis, and ongoing management of major neurological disorders

March 4, 2023  |  1:30 – 1:50 pm

Schedule a meeting with our team.

Interested in a demo of our solutions and industry-leading diagnostic and clinically focused reports? Our team will be on the ground and ready to answer your questions.

Richard Hausmann

Chief Executive Officer (CEO)

Hans-Peter Huber
Vice President European Sales
Julia Tsvietkova

Marketing Coordinator

Nelly Berger
Junior Sales Representative, D-A-C-H
Elena Bonke
EU Clinical Application Specialist
Guglielmo Manco
EU Clinical Application Specialist

Go beyond neurological image quantification.

For conditions such as dementia, multiple sclerosis, traumatic brain injury, and epilepsy, our platform supports earlier disease detection; faster, more efficient, differential diagnostic support; longitudinal tracking and prediction of disease progression; and detection and management of side effects.

Our AI solutions include:

*WIP – not yet cleared for clinical use.
Play Video
Play Video


cDSI is an imaging AI tool that supports the entire patient care pathway for major neurological disorders, including detection, differentiation, and ongoing management.


cMRI is a neurological imaging tool that enables fully automated, objective quantification of disease-specific abnormalities and patterns from MRI images, including probabilities of specific diagnoses.
Play Video

Dementia Differential Analysis report

The new Dementia Differential Analysis report is based on MRI data only, using our cDSI application’s proprietary machine learning method that measures the similarity of disease-specific imaging biomarker values from the patient to those from 2,000+ patients with a confirmed neurodegenerative disease.

It provides the probabilities of the following diagnoses for each patient:

Clinically focused cMRI reports

Our new clinically focused cMRI reports facilitate patient management as well as communication between radiologists, neurologists, patients, and their caregivers. These include reports for:

Will we see you at ECR 2023?